Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism Read more
Roche’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes Read more
European Commission approves Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA) Read more
AbbVie Submits Regulatory Applications to FDA and EMA for Risankizumab (SKYRIZI) in Ulcerative Colitis Read more
FDA Approves Veklury (Remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment Read more
LYNPARZA (olaparib)Plus Abiraterone and Prednisolone Approved in Japan for the Treatment of BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Read more
SK bioscience and Vaxxas Enter Joint Development Agreement for Needle-Free Patch Delivery of Typhoid Vaccine Read more
FDA Grants Priority Review for XTANDI in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence Read more
FDA Approves ABRYSVO, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age Read more